Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elafibranor Pilot Study on Insulin Sensitivity
NCT01271777Phase 2Completed
- Sponsor
- Genfit
- Start
- Jan 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elafibranor in insulin resistance (IR), Abdominal adiposity (ABCD), sponsored by Genfit. Started Jan 2011; status: completed.
02
Drugs
elafibranor
03
Conditions
insulin resistance (IR)Abdominal adiposity (ABCD)
Beyond the preview
Go deeper on NCT01271777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271777.